Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
17 studies found for:    "congenital hyperinsulinism" OR "neonatal hyperinsulinism" OR "persistent hyperinsulinemic hypoglycemia" OR "familial hyperinsulinism"
Show Display Options
Rank Status Study
1 Recruiting A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Cohort 1;   Drug: Cohort 2;   Drug: Cohort 3;   Drug: Cohort 4
2 Recruiting Fluorodopa F 18 in Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: Fluorodopa F 18
3 Unknown  Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy
Condition: Congenital Hyperinsulinism
Intervention: Drug: Lanreotide autogel
4 Completed
Has Results
Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Other: Vehicle
5 Completed Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism
Condition: Non-focal Congenital Hyperinsulinism
Intervention: Procedure: restrictive pancreatic resection
6 Recruiting CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Glucagon;   Other: Placebo
7 Recruiting Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Drug: placebo
8 Recruiting Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia
Condition: Congenital Hyperinsulinism
Interventions: Drug: exendin-(9-39);   Other: placebo
9 Completed Sandostatine® LP and Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: Sandostatine LP
10 Available Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia
Condition: Congenital Hyperinsulinism
Intervention: Drug: Pasireotide
11 Active, not recruiting Phase II Safety and Efficacy Study of F-DOPA PET/CT in Children With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism (CHI);   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
12 Unknown  Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism
Condition: Conservatively Treated CHI Patients
Intervention:
13 Active, not recruiting Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Conditions: Congenital Hyperinsulinism;   Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy;   CHI;   PHHI
Interventions: Drug: F-DOPA;   Radiation: PET scan
14 Available Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
Conditions: Hyperinsulinemic Hypoglycemia, Persistent;   Congenital Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
15 Recruiting Sirolimus for the Treatment of Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: Sirolimus
16 Available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism;   Beckwith-Wiedemann Syndrome;   Insulinoma
Intervention: Drug: 18F-DOPA
17 Recruiting 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Conditions: Insulinoma;   Nesidioblastosis
Intervention: Drug: 68Ga-NOTA-exendin-4

Study has passed its completion date and status has not been verified in more than two years.